These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification and characterization of α1 -antitrypsin in fibrin clots. Talens S, Malfliet JJ, van Hal PT, Leebeek FW, Rijken DC. J Thromb Haemost; 2013 Jul; 11(7):1319-28. PubMed ID: 23648095 [Abstract] [Full Text] [Related]
3. Optimizing the screening of alpha-1 antitrypsin deficiency using serum protein electrophoresis. Wauthier L, Jacques S, Delanghe J, Favresse J. Clin Chem Lab Med; 2023 Feb 23; 61(3):427-434. PubMed ID: 36420543 [Abstract] [Full Text] [Related]
4. The Association Between α1-Antitrypsin and Coronary Artery Ectasia. Turhan Caglar FN, Ksanski V, Polat V, Ungan I, Kural A, Ciftci S, Demir B, Ugurlucan M, Akturk F, Karakaya O. Angiology; 2016 Nov 23; 67(10):927-931. PubMed ID: 26953238 [Abstract] [Full Text] [Related]
5. [Development of a laboratory test on dried blood spots for facilitating early diagnosis of alpha-1-antitrypsin deficiency]. Balduyck M, Chapuis Cellier C, Roche D, Odou MF, Joly P, Madelain V, Vergne A, Nouadje G, Lafitte JJ, Porchet N, Beaune P, Zerimech F. Ann Biol Clin (Paris); 2014 Nov 23; 72(6):689-704. PubMed ID: 25486665 [Abstract] [Full Text] [Related]
7. [The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in population of Central Poland--preliminary results from newborn screening]. Chorostowska-Wynimko J, Struniawski R, Popławska B, Borszewska-Kornacka M. Pneumonol Alergol Pol; 2012 Nov 23; 80(5):450-3. PubMed ID: 22926906 [Abstract] [Full Text] [Related]
8. Efficacy of the detection of the alpha1-antitrypsin "Z" deficiency variant by routine serum protein electrophoresis. Slev PR, Williams BG, Harville TO, Ashwood ER, Bornhorst JA. Am J Clin Pathol; 2008 Oct 23; 130(4):568-72. PubMed ID: 18794049 [Abstract] [Full Text] [Related]
9. NullCanada: A novel α1-antitrypsin allele with in cis variants Glu366Lys and Ile100Asn. Chen S, DeMarco ML, Estey MP, Kyle B, Parker ML, Agbor TA, Kawada P, Speevak M, Nelson TN, Mattman A. Clin Biochem; 2020 May 23; 79():23-27. PubMed ID: 32087139 [Abstract] [Full Text] [Related]
10. Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO. Koepke J, Dresel M, Schmid S, Greulich T, Beutel B, Schmeck B, Vogelmeier CF, Janciauskiene S, Koczulla AR. PLoS One; 2015 May 23; 10(1):e0117497. PubMed ID: 25635861 [Abstract] [Full Text] [Related]
13. Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Mulgrew AT, Taggart CC, Lawless MW, Greene CM, Brantly ML, O'Neill SJ, McElvaney NG. Chest; 2004 May 23; 125(5):1952-7. PubMed ID: 15136414 [Abstract] [Full Text] [Related]
14. The role of augmentation therapy in alpha-1 antitrypsin deficiency. Kueppers F. Curr Med Res Opin; 2011 Mar 23; 27(3):579-88. PubMed ID: 21226542 [Abstract] [Full Text] [Related]